| scholarly article | Q13442814 |
| P2093 | author name string | G Wang | |
| J Chen | |||
| F Xu | |||
| M Cai | |||
| M Ma | |||
| K Tao | |||
| J Bai | |||
| X Shuai | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Cellular senescence: when bad things happen to good cells | Q29615561 | ||
| Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence | Q29620428 | ||
| The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival | Q33705252 | ||
| Mechanisms of regulatory diversity within the p53 transcriptional network | Q34039841 | ||
| Molecular characteristics of eight gastric cancer cell lines established in Japan | Q34099128 | ||
| EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression | Q34803805 | ||
| Pathological cyclic strain-induced apoptosis in human periodontal ligament cells through the RhoGDIα/caspase-3/PARP pathway | Q35018443 | ||
| Tumor cell senescence in cancer treatment | Q35143435 | ||
| Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage | Q35302120 | ||
| SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK. | Q36409515 | ||
| Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome | Q36580567 | ||
| Targeting the MDM2-p53 interaction for cancer therapy | Q37177586 | ||
| The Bmi-1 polycomb group gene in skin cancer: regulation of function by (-)-epigallocatechin-3-gallate | Q37233196 | ||
| Roles of the EZH2 histone methyltransferase in cancer epigenetics | Q37250591 | ||
| Epigenetic factors in cancer development: polycomb group proteins | Q37822735 | ||
| p53 as an intervention target for cancer and aging | Q38152454 | ||
| Let-7a inhibits proliferation and induces apoptosis by targeting EZH2 in nasopharyngeal carcinoma cells | Q38495053 | ||
| Downregulation of Ezh2 expression by RNA interference induces cell cycle arrest in the G0/G1 phase and apoptosis in U87 human glioma cells | Q39275514 | ||
| EZH2-dependent chromatin looping controls INK4a and INK4b, but not ARF, during human progenitor cell differentiation and cellular senescence. | Q39433602 | ||
| Weak p53 permits senescence during cell cycle arrest | Q39635569 | ||
| DNMT3a plays a role in switches between doxorubicin-induced senescence and apoptosis of colorectal cancer cells | Q39703300 | ||
| Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer | Q39743771 | ||
| Growth stimulation leads to cellular senescence when the cell cycle is blocked | Q39925937 | ||
| Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. | Q40273857 | ||
| Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2. | Q53121833 | ||
| A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy | Q74117541 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| P304 | page(s) | 211-218 | |
| P577 | publication date | 2014-04-16 | |
| P1433 | published in | Cell Proliferation | Q1952798 |
| P1476 | title | Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin in p53 mutant gastric cancer cells | |
| P478 | volume | 47 |
| Q64118957 | Curcumin inhibits liver metastasis of gastric cancer through reducing circulating tumor cells |
| Q36237945 | DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis |
| Q50479840 | Developmental epigenetic programming of adult germ cell death disease: Polycomb protein EZH2-miR-101 pathway. |
| Q50115221 | EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis |
| Q42365783 | EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis. |
| Q37392656 | EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma |
| Q55106988 | Epigenetic Contribution of High-Mobility Group A Proteins to Stem Cell Properties. |
| Q50324483 | Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program |
| Q42178342 | MiR-330-3p inhibits gastric cancer progression through targeting MSI1. |
| Q46258700 | Naringin protects myocardial cells from doxorubicin‑induced apoptosis partially by inhibiting the p38MAPK pathway |
| Q36444065 | Retinoblastoma-binding Protein 4-regulated Classical Nuclear Transport Is Involved in Cellular Senescence |
| Q91704977 | Targeting epigenetics in sarcomas through EZH2 inhibition |
Search more.